# SODIUM POLYSTYRENE SULFONATE

NDC: 11534-166
Generic name: sodium polystyrene sulfonate
Labeler / Manufacturer: SUNRISE PHARMACEUTICAL, INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL, RECTAL
Marketing started: 20170124

FDA application: ANDA204071

## Active ingredients

- SODIUM POLYSTYRENE SULFONATE: 4.1 meq/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11534-166"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11534-166
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c73b9661-2378-4336-8be0-098e7c1ae522